Scholars Central

Conference abstractPublished 1 Oct 2012

Stem cell-based therapy for dry AMD

Authors: Nady Golestaneh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A ge-related macular degeneration (AMD) is the leading cause of blindness in people over age 55 in the U.S. and the developed world. AMD is a multifactorial disease and there is no adequate animal model that recapitulates key characteristics of dry AMD. The lack of a robust model for AMD is a major impediment for mechanistic studies and drug development. Consequently, effective treatments for AMD are not available, although vitamin supplementation is recommended and is modestly beneficial for a small population of patients. Therefore, the need for novel therapeutic and preventive strategies is pressing. Recent generation of RPE cells from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), offers new promise for cell replacement therapy and disease modeling in AMD Modeling dry AMD in vitro could be an invaluable tool to study cellular and molecular mechanisms underlying AMD and to screen for compounds that reverse pathologic features, as a step towards drug development. Nonetheless, a reprogramming- based model of AMD would need to take genetic, environmental and epigenetic factors into consideration to reproduce a physiologically relevant in vitro model. In addition, successful cell-based therapy in dry AMD requires: 1) generation of patient-specific bona fide RPE cells that are morphologically and physiologically similar to native RPE, 2) RPE monolayer on a biodegradable matrix that allows transplantation of an intact epithelium. An intact structure of the RPE monolayer cultured on a biodegradable matrix not only facilitates transplantation into the sub-retinal space but also is crucial for RPE survival, cellular function and integration in the host retina.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Nady Golestaneh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels